Monday, December 29, 2014

Best Defensive Companies To Own In Right Now

Best Defensive Companies To Own In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company markets Xyrem, a sodium oxybate oral solution for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR extended-release capsules for the treatment of obsessive compulsive disorder. Its product candidates under clinical development include JZP-6, a Phase III pivotal clinical trials completed product for the treatment of fibromyalgia; and JZP-8, an intranasal formulation of clonazepam, which has completed Phase II clinical trial for the treatment of acute repetitive seizures in epilepsy and solid oral dosage forms of sodium oxybate. The company sells its products through specialty sales force targeting sleep specialists, psychiatrists, neurologists, and pulmonologists. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headq uartered in Palo Alto, California.

Advisors' Opinion:
  • [By Sean Williams]

    What: Shares of biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ  ) dipped as much as 10% after the company reported its first-quarter results and following regulatory comments with regard to generic competition to its lead drug.

  • [By Jake L'Ecuyer]

    Shares of Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) got a boost, shooting up 7.77 percent to $123.65 after the company announced its plans to buy Gentium SpA (NASDAQ: GENT) for around $1 billion.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-defensive-companies-to-own-in-right-now-3.html

No comments:

Post a Comment